Department of Anesthesiology, Tehran University Children's Hospital Medical Center, Tehran, Iran.
Anesth Analg. 2010 Nov;111(5):1252-8. doi: 10.1213/ANE.0b013e3181f1bd6f. Epub 2010 Aug 24.
Oral enteric contrast medium (ECM) is frequently administered to achieve visualization of the gastrointestinal tract during abdominal evaluation with computed tomography (CT). Administering oral ECM less than 2 hours before sedation/anesthesia violates the nothing-by-mouth guidelines and in theory may increase the risk of aspiration pneumonia. In this study we measured the residual gastric fluid when using a protocol in which ECM is administered up to 1 hour before anesthesia/sedation. We hypothesized that patients receiving ECM 1 hour before anesthesia/sedation would have residual gastric fluid volume (GFV) >0.4 mL/kg.
Anesthesia and radiology reports, CT images, and department incident reports were reviewed between January 2005 and June 2009 for all patients who required sedation/anesthesia for abdominal CT. For each patient, the volume of contrast or stomach fluid was calculated using a region of interest outlining the stomach portion containing high-attenuation fluid and low-attenuation of other gastric contents. Information obtained from anesthesia/sedation reports included demographic characteristics, presenting pathology, drugs used for anesthesia/sedation induction and maintenance, airway interventions, method for securing endotracheal tube, and complications related to ECM administration, including oxygen desaturation, vomiting, coughing, bronchospasm, laryngospasm, and aspiration.
We identified 365 patients (mean age = 32 months; range = 0.66 to 211.10 months) who received oral/IV contrast material before anesthesia/sedation for abdominal CT and 47 patients (mean age = 52 months; range = 0.63 to 215.84 months) who received only IV contrast material and followed the traditional fast. For those who received oral contrast, the mean contrast volume administered was 18.10 mL/kg (range = 1.5 to 82.76 mL/kg). The median GVF 1 hour after completing the oral contrast was significantly higher than that in patients who received only IV contrast (0.38 mL/kg vs. 0.15 mL/kg, P = 0.0049). GFV exceeded 0.4 mL/kg in 189 patients (178 of 365 [49%] in the oral contrast group vs. 11 of 47 [23%] in the IV contrast group) (χ(2) = 10.7874, P = 0.0010). Among those who received oral contrast, 207 patients had general anesthesia and 158 patients had deep sedation. Two cases of vomiting were reported in the general anesthesia group with no evidence of pulmonary aspiration identified.
For children receiving an abdominal CT, the residual GFV exceeded 0.4 mL/kg in 49% (178/365) of those who received oral ECM up to 1 hour before anesthesia/sedation in comparison with 23% (11/47) of those who received IV-only contrast.
口服肠道造影剂(ECM)常用于腹部 CT 评估时使胃肠道可视化。在镇静/麻醉前 2 小时内给予口服 ECM 违反了禁食指南,理论上可能会增加吸入性肺炎的风险。在这项研究中,我们测量了使用 ECM 给药方案时的胃内残留液量,该方案在麻醉/镇静前 1 小时内给予 ECM。我们假设在接受 ECM 1 小时后进行麻醉/镇静的患者胃内残留液量(GFV)>0.4 mL/kg。
回顾 2005 年 1 月至 2009 年 6 月期间所有需要镇静/麻醉进行腹部 CT 的患者的麻醉和放射学报告、CT 图像和科室事件报告。对于每位患者,使用包含高衰减液体和低衰减其他胃内容物的胃部分区域的感兴趣区域计算对比剂或胃液的体积。从麻醉/镇静报告中获得的信息包括人口统计学特征、表现病理学、麻醉/镇静诱导和维持使用的药物、气道干预、气管内导管固定方法以及与 ECM 给药相关的并发症,包括氧饱和度下降、呕吐、咳嗽、支气管痉挛、喉痉挛和吸入。
我们确定了 365 名(平均年龄=32 个月;范围=0.66 至 211.10 个月)在接受麻醉/镇静前接受口服/静脉造影剂进行腹部 CT 检查的患者和 47 名(平均年龄=52 个月;范围=0.63 至 215.84 个月)仅接受静脉造影剂并遵循传统禁食的患者。对于接受口服对比剂的患者,平均给予的对比剂体积为 18.10 mL/kg(范围=1.5 至 82.76 mL/kg)。口服对比剂完成后 1 小时的胃内残留液中位数明显高于仅接受静脉对比剂的患者(0.38 mL/kg 比 0.15 mL/kg,P=0.0049)。在 189 名患者(口服对比剂组 178 名[49%],静脉对比剂组 11 名[23%])中胃内残留液量超过 0.4 mL/kg(χ²=10.7874,P=0.0010)。在接受口服对比剂的患者中,207 名患者接受全身麻醉,158 名患者接受深度镇静。全身麻醉组报告了 2 例呕吐,但未发现肺吸入证据。
对于接受腹部 CT 检查的儿童,与仅接受静脉造影剂的患者(23%,11/47)相比,在接受麻醉/镇静前 1 小时内接受口服 ECM 的患者中,胃内残留液量超过 0.4 mL/kg 的比例为 49%(178/365)。